Annovis Bio raises $8.7M to advance experimental Parkinson’s and Alzheimer’s treatment


The additional capital includes more than $1 million invested by the company's board and management.

Previous Diversicare Healthcare Services names Steve Nee CEO
Next EZ Induction video game developed at Cincinnati Children's lands licensing deal with Columbus' LittleSeed